746
Participants
Start Date
September 30, 2006
Primary Completion Date
August 31, 2008
Study Completion Date
August 31, 2008
Mometasone Furoate/Formoterol Fumarate Combination MDI 100/10 mcg BID
MF/F 100/10 mcg via a metered dose inhaler (MDI) twice daily for 26 weeks
Mometasone Furoate MDI (MF MDI)
MF 100 mcg via metered dose inhaler twice daily for 26 weeks
Formoterol Fumarate 10 mcg
F via metered dose inhaler 10 mcg twice a day for 26 weeks
Placebo
Placebo metered dose inhaler twice a day for 26 weeks
Collaborators (1)
Novartis
INDUSTRY
Organon and Co
INDUSTRY